- Home
- / EZZ Life Science Holdings
EZZ Life Science Holdings
Stock Price
$5
2024-10-04
Market Capitalization
$220.3 M
2024-10-04
Revenue
$66.9 M
FY, 2025
EZZ Life Science Holdings Summary
Company Summary
- Overview
- EZZ Life Sciences is a genomic life sciences company. It specializes in genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management.
- Type
- Public
- Status
- Active
- Founded
- 2015
- Website
- https://ezzlife.com.au/
- Cybersecurity rating
Table of Contents
EZZ Life Science Holdings Financials
Summary Financials
- Revenue (H1, 2026)
- $24.8M
- Gross profit (H1, 2026)
- $18.2M
- Net income (H1, 2026)
- ($641.0K)
- Cash (H1, 2026)
- $13.5M
- EBIT (H1, 2026)
- ($107.0K)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026